Fla., — CELEBRATION, Fla., Feb. 16, 2021 — Moffitt Cancer Center and AdventHealth have opened the doors of their joint Clinical Research Unit at AdventHealth Celebration, a specialized facility for early drug development, clinical trials and research.
The facility has 28 chairs in the infusion center to provide standard therapies and 13 newly added chairs in the clinical research unit reserved for investigational therapies. Care will be provided to patients with solid tumors and blood cancers.
“The opening of this unit will allow patients in Central Florida to access the latest investigational therapies,” said Dr. George Simon, executive medical director of the joint clinical research unit and infusion center. “As we launch more trials, we plan to offer cutting edge anti-cancer treatments, including novel targeted therapies, monoclonal antibodies, antibody-drug conjugates and other therapeutic platforms.”
The unit’s opening is the latest step in the two major cancer providers’ partnership. The first collaborative clinical trial of the partnership – a Phase I trial testing the effectiveness of a promising new combination therapy for lung cancer – launched in September. Several other collaborative investigator-initiated efforts are currently under development.
“At AdventHealth Celebration, we are combining our expertise and resources, providing even more Floridians with access to world-class cancer care close to home,” said Dr. Nikhil Khushalani, Assistant Center Director of Clinical Research Review and Partnerships and senior member of the Department of Cutaneous Oncology at Moffitt Cancer Center.
AdventHealth’s Central Florida Division encompasses more than 20 hospitals and ERs in the seven counties in and surrounding metro Orlando. The world-class hospitals, combined with a comprehensive outpatient care network, sees more than 3.4 million patient visits annually.
AdventHealth Orlando — the division’s flagship campus — boasts nationally and internally recognized programs, and serves as a major tertiary referral hospital for much of the Southeast, the Caribbean and Latin America. The organization has an expansive research portfolio with more than 500 clinical trials in progress.
AdventHealth has a deep commitment to serving the community and has a local financial impact of more than $1 billion annually. The organization and its employees are responsible for nearly 20 percent of Central Florida’s economy.
Learn more about the Central Florida Division on our Newsroom.
About Moffitt Cancer Center:
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT ( Call1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.
- Contact: CFD External Communications
- Tel: Call CFD External Communications at407-303-5950
- Email: Email CFD External Communications at[email protected]